Emeryville, Ca., USA - April 15, 2015, Emeryville, Ca., USA - NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, announces the appointment of Mark M. Sieczkarek as chairman of the board.
Article continues below
Mr. Sieczkarek has served as a director of NovaBay since January 2014. Mr. Sieczkarek was elected Chairman of Solta Medical, Inc. in June 2013, and in August 2013 was named interim President and Chief Executive Officer. He served in these positions until Solta Medical was acquired by Valeant Pharmaceuticals, Inc. in January 2014.
Prior to Solta Medical, Mr. Sieczkarek was President and Chief Executive Officer of Conceptus, Inc., where he oversaw the successful commercial launch of the Essure permanent birth control device.
He previously was Senior Vice President and President of The Americas and Europe for the leading ophthalmic company Bausch & Lomb, Inc., with responsibility for commercial operation in the United States, Canada Latin America, Europe and Africa.
Additionally, NovaBay announces the appointment of LI Xinzhou (Paul Li) to the Board of Directors, also effective April 10, 2015.
Mr. Li is Chairman, Executive Director of China Pioneer Pharma Holdings Limited, the exclusive distributor of NovaBay’s NeutroPhase Skin and Wound Cleanser in China and Southeast Asia.
Mr. Li founded China Pioneer Pharma in July 1996, and is responsible for managing the operations and planning, and for formulating the company’s strategies. He has more than 18 years of experience in the pharmaceutical services industry and has more than 20 years of experience in international trading and management.
Prior to China Pioneer Pharma, Mr. Li worked at the Hainan branch of Sumitomo Corporation. Mr. Li graduated from Jianghan Petroleum Normal School with a diploma in English and studied at the China Europe International Business School.
NovaBay also announces that current directors Charles J. Cashion and Tony Wicks have informed the Company’s Board that they will not stand for re-election at the 2015 annual meeting.
In addition to Mr. Li, Alex McPherson will stand for re-election to the Board at the 2015 annual meeting of stockholders. ■